Covishield stock for 45+ age group left for 12 days: AAP MLA Atishi

By: |
May 26, 2021 6:45 PM

In a vaccination bulletin issued online, she also said, "Yesterday, only 43,824 doses were administered in total, while the count was over 1.25 lakh or 1.4 lakh per day till recent time".

"For 18-44 age group, we were vaccinating over 80,00 people per day till a few days ago, but now it has totally halted, as we don't have doses for this category of beneficiaries," the Aam Aadmi Party (AAP) legislator said.

The Delhi government’s stock of Covishield vaccine for beneficiaries in the 45 and above age group is available for just 12 days, AAP MLA Atishi said on Wednesday and lamented that for the youth segment, vaccination remained halted for the third consecutive day due to lack of doses.

In a vaccination bulletin issued online, she also said, “Yesterday, only 43,824 doses were administered in total, while the count was over 1.25 lakh or 1.4 lakh per day till recent time”.

“For 18-44 age group, we were vaccinating over 80,00 people per day till a few days ago, but now it has totally halted, as we don’t have doses for this category of beneficiaries,” the Aam Aadmi Party (AAP) legislator said.

For the 45 and above group, about 2.92 lakh doses of Covishield is there in stock and this can be used for just 12 days of vaccination, while Covaxin stock which was available at a diminished scale till recently, is already exhausted, Atishi said.

On May 25, of the 43,824 doses administered, over 33,000 were given to those getting their first shots and about 10,000 for those receiving their second jabs, she added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: Over half crore people in Maharashtra fully vaccinated in five months
2Meet Hasmukh Rawal, MD, Mylab Discovery Solutions; Developer of CoviSelf, India’s first Covid-19 self-test kit
3Post-covid 19 complications: Considerations and management